Stock Surge: Astrazeneca plc ADR (AZN) Closes at 68.72, Marking a -0.10 Increase/Decrease

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

In the latest session, Astrazeneca plc ADR (NASDAQ: AZN) closed at $68.72 down -0.10% from its previous closing price of $68.79. In other words, the price has decreased by -$0.10 from its previous closing price. On the day, 3.2 million shares were traded. AZN stock price reached its highest trading level at $69.37 during the session, while it also had its lowest trading level at $68.615.

Ratios:

For a deeper understanding of Astrazeneca plc ADR’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 39.50 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.58. For the most recent quarter (mrq), Quick Ratio is recorded 0.70 and its Current Ratio is at 0.90. In the meantime, Its Debt-to-Equity ratio is 0.77 whereas as Long-Term Debt/Eq ratio is at 0.68.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Exane BNP Paribas on April 15, 2025, initiated with a Outperform rating and assigned the stock a target price of $75.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AZN now has a Market Capitalization of 214973349888 and an Enterprise Value of 134727999488. As of this moment, Astrazeneca’s Price-to-Earnings (P/E) ratio for their current fiscal year is 27.61, and their Forward P/E ratio for the next fiscal year is 13.43. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.40. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.88 while its Price-to-Book (P/B) ratio in mrq is 5.19. Its current Enterprise Value per Revenue stands at 2.45 whereas that against EBITDA is 7.371.

Stock Price History:

The Beta on a monthly basis for AZN is 0.36, which has changed by -0.13100052 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, AZN has reached a high of $87.68, while it has fallen to a 52-week low of $61.24. The 50-Day Moving Average of the stock is -2.70%, while the 200-Day Moving Average is calculated to be -2.87%.

Shares Statistics:

For the past three months, AZN has traded an average of 4.49M shares per day and 3578900 over the past ten days. A total of 3.10B shares are outstanding, with a floating share count of 3.10B. Insiders hold about 0.01% of the company’s shares, while institutions hold 16.62% stake in the company. Shares short for AZN as of 1749772800 were 7445913 with a Short Ratio of 1.52, compared to 1747267200 on 7342168. Therefore, it implies a Short% of Shares Outstanding of 7445913 and a Short% of Float of 0.23999999000000002.

Dividends & Splits

According to the company, the forward annual dividend rate for AZN is 1.55, from 3.1 in the trailing year. Against a Trailing Annual Dividend Yield of 0.045064688The stock’s 5-year Average Dividend Yield is 2.26. The current Payout Ratio is 66.98% for AZN, which recently paid a dividend on 2025-02-21 with an ex-dividend date of 2025-02-21. Stock splits for the company last occurred on 2015-07-27 when the company split stock in a 2:1 ratio.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.